Biome Australia Limited (BIO.AX)
AUD 0.57
(4.63%)
AUD 0.57
(4.63%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 8.27 Million AUD | 9.49% |
| 2023 | 7.55 Million AUD | -8.39% |
| 2022 | 8.25 Million AUD | -25.6% |
| 2021 | 11.09 Million AUD | 469.75% |
| 2020 | 1.94 Million AUD | 7.23% |
| 2019 | 1.81 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 7.17 Million AUD | -11.64% |
| 2024 Q4 | 8.27 Million AUD | 0.0% |
| 2024 FY | 8.27 Million AUD | 9.49% |
| 2024 Q2 | 7.17 Million AUD | 0.0% |
| 2023 Q2 | 7.79 Million AUD | 0.0% |
| 2023 FY | 7.55 Million AUD | -8.39% |
| 2023 Q3 | 7.55 Million AUD | -3.04% |
| 2023 Q1 | 7.79 Million AUD | -5.52% |
| 2023 Q4 | 8.12 Million AUD | 7.43% |
| 2022 Q2 | 10.03 Million AUD | 0.0% |
| 2022 FY | 8.25 Million AUD | -25.6% |
| 2022 Q4 | 8.25 Million AUD | 0.0% |
| 2022 Q3 | 8.25 Million AUD | -17.76% |
| 2022 Q1 | 10.03 Million AUD | 301.36% |
| 2021 Q4 | 2.49 Million AUD | -0.0% |
| 2021 Q3 | 2.49 Million AUD | 0.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 FY | 11.09 Million AUD | 469.75% |
| 2020 FY | 1.94 Million AUD | 7.23% |
| 2019 FY | 1.81 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 25.55 Million AUD | 67.608% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -395.195% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -59.678% |
| Patrys Limited | 4.16 Million AUD | -98.886% |
| Orthocell Limited | 26.61 Million AUD | 68.902% |
| Imugene Limited | 151.39 Million AUD | 94.533% |
| Noxopharm Limited | 6.78 Million AUD | -22.009% |
| PYC Therapeutics Limited | 91.23 Million AUD | 90.928% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | 45.808% |
| Prescient Therapeutics Limited | 20.39 Million AUD | 59.413% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | 23.892% |
| Cynata Therapeutics Limited | 8.38 Million AUD | 1.329% |
| CSL Limited | 56.93 Billion AUD | 99.985% |
| Arovella Therapeutics Limited | 13.28 Million AUD | 37.697% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -161.958% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 96.419% |
| Starpharma Holdings Limited | 36.81 Million AUD | 77.517% |
| Nanollose Limited | 241.95 Thousand AUD | -3320.854% |
| Memphasys Limited | 12.43 Million AUD | 33.414% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -35.241% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -52.262% |
| Amplia Therapeutics Limited | 14.84 Million AUD | 44.246% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 92.641% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -222.748% |
| Race Oncology Limited | 20.22 Million AUD | 59.084% |
| Nyrada Inc. | 5.9 Million AUD | -40.112% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 97.922% |
| Dimerix Limited | 32.07 Million AUD | 74.198% |
| PharmAust Limited | 11.12 Million AUD | 25.601% |
| Immutep Limited | 147.44 Million AUD | 94.387% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 94.647% |
| Alterity Therapeutics Limited | 19.22 Million AUD | 56.945% |
| BTC Health Limited | 5.14 Million AUD | -60.752% |
| Acrux Limited | 8.96 Million AUD | 7.656% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 96.662% |
| Biotron Limited | 493.47 Thousand AUD | -1577.243% |
| Tissue Repair Ltd | 19.38 Million AUD | 57.313% |
| AdAlta Limited | 5.57 Million AUD | -48.516% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 88.51% |
| Hexima Limited | 2.26 Million AUD | -264.776% |
| AnteoTech Limited | 9.38 Million AUD | 11.772% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 69.782% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -29.942% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -13.082% |
| Actinogen Medical Limited | 21.31 Million AUD | 61.163% |
| Immuron Limited | 15.54 Million AUD | 46.773% |
| Argenica Therapeutics Limited | 16.37 Million AUD | 49.463% |